Results 251 to 260 of about 1,511,239 (338)
Therapeutic strategies for MMAE‐resistant bladder cancer through DPP4 inhibition
We established monomethyl auristatin E (MMAE)‐resistant bladder cancer (BC) cell lines by exposure to progressively increasing concentrations of MMAE in vitro. RNA sequencing showed DPP4 expression was increased in MMAE‐resistant BC cells. Both si‐DPP4 and the DPP4 inhibitor sitagliptin suppressed the viability of MMAE‐resistant BC cells.
Gang Li +10 more
wiley +1 more source
Artificial intelligence in nongynecologic cytology: A systematic review of current research and commercial tools. [PDF]
Byambadorj T, Alam MR, Chong Y.
europepmc +1 more source
ANALYSIS OF EU REGULATION OF MARKET ADMISSION OF NON-REPORTING MOBILE EQUIPMENT
Summary This article presents a comprehensive analysis and generalization of the EU’s regulatory framework regarding the market access of non-road mobile machinery (NRMM).The research objective was to study and systematize current European legislative acts, directives, and regulations, particularly the new Regulation (EU) 2025/14, which governs the ...
openaire +1 more source
Nanosecond infrared laser (NIRL) low‐volume sampling combined with shotgun lipidomics uncovers distinct lipidome alterations in oropharyngeal squamous cell carcinoma (OPSCC) of the palatine tonsil. Several lipid species consistently differentiate tumor from healthy tissue, highlighting their potential as diagnostic markers.
Leonard Kerkhoff +11 more
wiley +1 more source
Scanning the evidence: A pilot study evaluating the accuracy of sonographer reporting in the Republic of Ireland. [PDF]
Tyler J, Waring L, Bolton GC, Miller PK.
europepmc +1 more source
Non Metallic Anterior Chamber Foreign Body: A Case Report
Nabilah Afifah +2 more
openalex +1 more source
We show that the majority of the 18 analyzed recurrent cancer‐associated ERBB4 mutations are transforming. The most potent mutations are activating, co‐operate with other ERBB receptors, and are sensitive to pan‐ERBB inhibitors. Activating ERBB4 mutations also promote therapy resistance in EGFR‐mutant lung cancer.
Veera K. Ojala +15 more
wiley +1 more source
Examining the underreporting of social determinants of health in randomized controlled trials published in spine journals. [PDF]
Megafu MN +9 more
europepmc +1 more source

